Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Phibro Anl Htlh A (PAHC)

Phibro Anl Htlh A (PAHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 852,588
  • Shares Outstanding, K 40,503
  • Annual Sales, $ 1,018 M
  • Annual Income, $ 2,420 K
  • EBIT $ 72 M
  • EBITDA $ 109 M
  • 60-Month Beta 0.51
  • Price/Sales 0.86
  • Price/Cash Flow 10.26
  • Price/Book 3.40

Options Overview Details

View History
  • Implied Volatility 100.44% ( -5.88%)
  • Historical Volatility 30.07%
  • IV Percentile 97%
  • IV Rank 76.24%
  • IV High 129.86% on 02/08/24
  • IV Low 6.06% on 05/22/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 63
  • Open Int (30-Day) 97

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.41
  • Number of Estimates 4
  • High Estimate 0.48
  • Low Estimate 0.34
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +24.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.24 +2.32%
on 12/30/24
24.42 -15.19%
on 12/12/24
-2.66 (-11.38%)
since 11/29/24
3-Month
20.24 +2.32%
on 12/30/24
25.98 -20.28%
on 11/12/24
-1.81 (-8.04%)
since 09/30/24
52-Week
10.03 +106.38%
on 02/08/24
25.98 -20.28%
on 11/12/24
+9.13 (+78.84%)
since 12/29/23

Most Recent Stories

More News
Bruker Adds Another 1.2 GHz NMR System in Switzerland, Stock Climbs

Bruker Corporation’s BRKR 1.2 GHz Ascend Nuclear Magnetic Resonance (NMR) spectrometer has been accepted at the Swiss High-field NMR Facility, operated jointly by the University of Basel, ETH Zürich,...

BRKR : 58.20 (-0.36%)
PEN : 238.00 (-0.77%)
PAHC : 20.98 (-0.33%)
HAE : 76.49 (-1.39%)
MYGN Stock Might Gain From the New Recognition of RiskScore Study

Myriad Genetics, Inc.’s MYGN MyRisk Hereditary Cancer Test with RiskScore study has been named as one of its top 10 significant advances in genomic medicine by the American Journal of Human Genetics....

MYGN : 13.48 (+0.45%)
PEN : 238.00 (-0.77%)
PAHC : 20.98 (-0.33%)
HAE : 76.49 (-1.39%)
Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?

Teleflex TFX recently launched its new Pressure Injectable Arrowg+ard Blue Plus MSB Procedure Kit in Europe, the Middle East and Africa (EMEA). This is regarded as a significant addition to the company’s...

TFX : 176.92 (-1.44%)
PEN : 238.00 (-0.77%)
PAHC : 20.98 (-0.33%)
HAE : 76.49 (-1.39%)
New NCCN Guidelines Boost Myriad Genetics' Prolaris: Stock to Gain?

Myriad Genetics, Inc.’s MYGN Prolaris prostate cancer prognostic test has been reinforced as an ‘Advanced Tool’ by the National Comprehensive Cancer Network (“NCCN”) in the fight against prostate...

MYGN : 13.48 (+0.45%)
PEN : 238.00 (-0.77%)
PAHC : 20.98 (-0.33%)
HAE : 76.49 (-1.39%)
CRL Stock to Gain From the Global Biotech Incubator Program Launch

Charles River Laboratories International, Inc. CRL has launched the Charles River Incubator Program (“CIP”) via its Global Innovation Center of Excellence (CoE). The initiative is designed to support...

PEN : 238.00 (-0.77%)
PAHC : 20.98 (-0.33%)
CRL : 182.97 (-1.71%)
HAE : 76.49 (-1.39%)
Phibro: Fiscal Q1 Earnings Snapshot

Phibro: Fiscal Q1 Earnings Snapshot

PAHC : 20.98 (-0.33%)
HSIC Q3 Earnings Top, Margins Down, Stock Gains in Premarket

Henry Schein, Inc. HSIC registered adjusted earnings per share (EPS) of $1.22 in the third quarter of 2024, down 7.6% from the year-ago figure. However, the metric exceeded the Zacks Consensus Estimate...

VCYT : 40.12 (-0.15%)
HQY : 97.36 (+1.10%)
HSIC : 69.68 (-1.05%)
PAHC : 20.98 (-0.33%)
BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket

Bio-Rad Laboratories, Inc. BIO posted third-quarter 2024 adjusted earnings per share (EPS) of $2.01, which beat the Zacks Consensus Estimate by 57%. However, the bottom line decreased 13.7% from the prior-year...

VCYT : 40.12 (-0.15%)
HQY : 97.36 (+1.10%)
BIO : 327.02 (-1.16%)
PAHC : 20.98 (-0.33%)
Finding Great Top-Ranked Momentum Stocks to Buy Now

Wall Street is sitting on its hands on Monday and Tuesday waiting for Alphabet, Microsoft, Apple, Amazon, and other mega-cap technology stocks to report their results in the final week of October.See the...

PAHC : 20.98 (-0.33%)
WBA Stock Up on Q4 Earnings & Revenues Beat, Unveils Strategic Action

Walgreens Boots Alliance, Inc. WBA delivered adjusted earnings per share (EPS) of 39 cents in the fourth quarter of fiscal 2024, down 41.8% from the year-ago quarter’s figure (down 40.8% at constant...

VCYT : 40.12 (-0.15%)
HQY : 97.36 (+1.10%)
WBA : 9.40 (-2.29%)
PAHC : 20.98 (-0.33%)

Business Summary

Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro...

See More

Key Turning Points

3rd Resistance Point 22.59
2nd Resistance Point 22.22
1st Resistance Point 21.63
Last Price 20.98
1st Support Level 20.67
2nd Support Level 20.30
3rd Support Level 19.71

See More

52-Week High 25.98
Last Price 20.98
Fibonacci 61.8% 19.89
Fibonacci 50% 18.01
Fibonacci 38.2% 16.13
52-Week Low 10.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar